iBeta is now authorized to review, verify and certify that particular electronic prescribers or electronic pharmacy applications meet the requirements of DEA’s regulations governing EPCS.
The DEA-EPCS program allows practitioners, hospitals and pharmacies the option to utilize electronic prescriptions for controlled substances. The revised rule (June 1, 2010) allows the use of a biometric as a substitute for a hard token or a password.
The DEA notes that practitioners might find strong passwords more burdensome than a biometric or token over the long run. “Doctors and other prescribers are much less likely to leave their biometric at home, but if they forget their token I guess they will need to switch back to a pad for the day. Any technology that makes a physician’s day easier, benefits both the doctor and the patient.” said Dr. Wilson, iBeta’s Director of Biometrics.
About iBeta
Headquartered in Metro Denver (Aurora) Colorado, iBeta offers a full range of software quality services. Our services encompass many different software quality activities, such as quality assurance, functionality testing, performance testing, compatibility testing, code reviews, IV & V, and test plan engineering. Our testing labs can handle a wide variety of software architectures, such as simple web-based applications, stand-alone software packages, and complex client-server architectures.
More information about iBeta’s biometrics department and its QA Testing services in general, can be found at iBeta’s website at http://www.iBeta.com.
Contact: Dr. Kevin Wilson PhD, kwilson@ibeta.com;
